Learning by Heart: The Effectiveness of an EF Training Program for Pre-schoolers With a Severe CHD

Recruiting N/A Interventional Study
Congenital Heart Disease Executive Dysfunction Attention Disorder
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
4 – 7
Sex
Any
Study type
Interventional
Purpose
Treatment
Participants needed
141 (estimated)
Sponsor
Erasmus Medical Center · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Advances in prenatal and neonatal care have improved outcomes in children with severe congenital heart disease (CHD). With the increase in survival, neurocognitive problems such as executive functioning (EF) impairments have become more apparent in these children. EF problems have cascading negative effects on a child's development. New insights in EF development suggest that in otherwise physical…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
In order to be eligible to participate in this study, a child must meet all of the following criteria: * Aged 4.0 - 6.0 years upon inclusion OR aged 6.0-7.0 years who are still in kindergarten (group 1 \& 2 of the Dutch school system) * Required CHD surgery in the first six months of life (with or …
Contacts

Eveline Oppelaar

0031107040209

e.oppelaar@erasmusmc.nl

CONTACT

André Rietman

0031107036090

a.rietman@erasmusmc.nl

CONTACT